A Word of Caution

Discussion in 'Merck' started by anonymous, Apr 22, 2016 at 10:48 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


    Where's the layoffs jack-off?
     

  2. anonymous

    anonymous Guest

    I have warned you useless scum that you will be gone by mid year and it is now beginning and about time. My returns will be great and the day of delislinging over.
     
  3. anonymous

    anonymous Guest

    I'd estimate that this group is 7-10% smaller than it was 18 months ago. The "layoffs" aren't happening---they're too expensive. The headcount, however, is always being reduced. Merck is relieving itself of our services one rep at a time, usually at the end of a dagger.
     
  4. anonymous

    anonymous Guest

    Where's the layoffs jack-off? No calls being made anywhere in the country this Friday. When are you going to start sucking on me?
     
  5. anonymous

    anonymous Guest

    your estimated are wrong
    Like everything else you say
     
  6. anonymous

    anonymous Guest

    After Kenny and gang gets beat up over our earnings manana, rest assured cuts will come soonafter. Earnings news going to be bad mainly due to tanking mature products and patent expirations.
     
  7. anonymous

    anonymous Guest

    Yeah sure thing dick lick
     
  8. anonymous

    anonymous Guest

    The earnings will be fine jack ass. You must be an MBA because you know nothing about finances and reporting. The MBA's of the world are part of the reason our company has tanked. Now, stop taking up the back shoot and do something productive for the company.
     
  9. anonymous

    anonymous Guest

    Yeah- you really have your hand on the financial pulse of the company you nit-wit. Go back to school. Keep your hand on the pulse of that other thing you do
     
  10. anonymous

    anonymous Guest

    If I see my manager once a month it is rare. Mine is checked out!
     
  11. anonymous

    anonymous Guest

    I think the managers are just as curious as we are. They aren't privvy to any details.
     
  12. anonymous

    anonymous Guest

    of course they do jack off
     
  13. anonymous

    anonymous Guest

    I initially dismissed this post as an alarmist who was making noise.

    However in light of the events of the last couple of weeks, as were predicted, I am now very concerned that this was a accurate message.
     
  14. anonymous

    anonymous Guest

    Trust me, you do not want to be a rep carrying Boresomra, Dullaira and Assmanex. Gone by this time next year or sooner. PC will only be Januvia, even that might but you a few more years. Cuts, cuts, cuts, leaves very few places to scurry to these days. Pay close attention to the upcoming EBB.
     
  15. anonymous

    anonymous Guest

    Agree. With the $3bil patent expirys this year, no revenue generating drug in the pipeline, every prod and vaccine(except Jan) is below plan, and the top heavy upper manager structure sucking down the big bucks, some merger has to happen this year. Unfortunately, Merck now is the little fish to get sucked up & spit out. If not this EBB, then the 3rd Qtr EBB, a merger announcement is coming. This company is unsustainable in its current condition.
     
  16. anonymous

    anonymous Guest

    I have warned and notified you of the actions to materialize this year. Most of you will be terminated!
     
  17. anonymous

    anonymous Guest

    im betting Merck sells its PC products and focuses on higher revenue producing areas. Belsomara is way below plan. Look out next year when managed care places generic DPP4 from TAkeda in a favored position. It will impact Januvia sales.
     
  18. anonymous

    anonymous Guest

    I know I would not want to be the belsomara rep.

    I admit I have no idea what will happen but common sense tells me no way in hell they keep 3 in a territory. Belsomara way below expectations and Dulera faces stiff headwind. There is no way to rationally justify it in 2017.

    I think the only person safe is Januvia rep and 50/50 for the others. Sad but it's true and it's just the direction we are going. He'll Kenny even said that we have to be nimble and adjust to conditions.

    The only silver lining is that will get rid of close to half of the lame ass do nothing CTL. That group is as worthless as it gets. Ego the size of Rushmore and useless as a sterile hen. This company waste a fortune on middle management.

    Here is an idea, get rid of CTL's and their aimless director.........oh best of all, associate director or whatever goofy title the flatulant CTL likes today. Then I would take marketing to the woodshed as they have been just masterful the last few years. How many millions wasted on Juvasync and that Zetia combo joke. Now Belsomara. Great forecast folks. But they will blame everything on sales. Yep, point your finger at sales as the once proud organization circles the drain and the upper management team retires with millions.
     
  19. anonymous

    anonymous Guest

    Hey don't forget marketing and their success with Zontivity and Ragwiteck.

    Their efforts resulted in..............oh that's no more.
     
  20. anonymous

    anonymous Guest

    Went back and read through this thread. I believe the original poster. Thanks for the heads up. Please tell if you know dates, etc.